Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management and treatment of breast cancer.
Funds vital medical research into the detection and treatment of prostate cancer, as well as preventing the metastatic spread of the disease.
We are passionate and determined to improve heart health and beat heart disease through advances in knowledge and research.
Our aim is to reduce and ultimately eliminate the high incidence of chronic kidney disease and diabetes in Australia and around the world.
Supports health and wellbeing research for veterans, emergency service personnel and their families.
Driving collaboration, innovation and research to develop best-practice arts, design and health programs.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
The BHI provides a dynamic, state-of-the-art research environment for vital ‘bench to bedside’ research and research training opportunities. Affiliated with the Universities of Adelaide, Flinders and the University of South Australia, the BHI is a short walk from The Queen Elizabeth Hospital, allowing for a vital and active interface between researchers and clinicians.
All research groups have strong links to clinical divisions within the Hospital underpinning The Institute’s overarching focus on translational health research. This ‘bench to bedside’ approach is at the forefront of an emerging area of medical science that aims to improve public health through collaborative discoveries and innovations in patient care, education and research.
Research conducted by The Institute covers a broad spectrum, exploring causes, potential improvements in therapeutic outcomes and the prevention of some of the most serious and common health conditions facing our community today.
Research areas include;
Opened in 2009, the facility was proudly named after the first Professor of Medicine at the hospital and one of Australia’s leading medical researchers, the late Honourable Basil Hetzel AC. Revered world-wide for his pioneering work which discovered the link between iodized salt in the diet and the prevention of brain damage in newborns, Dr Hetzel’s groundbreaking research has helped millions of children in 130 countries where iodine is lacking.
His passion and drive to prevent brain damaged babies born as a result of iodine deficiency around the world has been recognized as one of the most significant medical discoveries of modern times.
Dr Hetzel has received numerous academic and humanitarian awards, not only for his landmark medical research but for his commitment, vision and leadership in the areas of public and community health.
His strong support for the translational medical research undertaken at the facility which proudly bears his name continues to inspire current researchers and those yet to make their mark in the field.
support the basil hetzel institute
Thanks to the incredible generosity of one of our very special donors, Dr Margaret Elcombe, our researchers have been awarded the Elcombe Pre-Clinical Project Grant to pursue a promising new treatment avenue for breast cancer that has spread which if successful would be far less toxic than current treatments. read more
Supported by The Hospital Research Foundation (THRF), Dr Ashish Shrestha’s research aims to develop a universal Hepatitis C virus vaccine and a DNA vaccine to provide effective protection against the Zika virus, currently there are no developed vaccines against either virus. read more
Research underway at the Basil Hetzel Institute for Translational Health Research (BHI) is tackling a serious problem facing many diabetics in the community – foot ulcers. read more
The proud recipient of The Hospital Research Foundation’s Mid-Career Fellowship for 2017, geographer and researcher Dr Danielle Taylor is kick-starting a three year project aimed at ensuring our community can live longer, healthier and more fulfilling lives in the comfort of their own homes. read more
Did you know bowel cancer is the second most commonly diagnosed cancer for both men and women in Australia? This is why lifesaving research into this heartbreaking disease is so important, and we are so proud to support work in this area.
With the support of our Development Grant of $200,000 Professor Peter-John Wormald and his team are translating a gel now used to treat inflammation after sinus infection to a new treatment for people living with chronic pain after back surgery. read more
We're excited to announce Professor John Beltrame is the recipient of our inaugural Basil Hetzel Translational Grant. With his team, Prof Beltrame will pioneer the causes and treatment of patients living with chest pain following an ‘unexplained heart attack’.
In 2015 we introduced you to the incredible work of Dr Bill Panagopoulos, who was leading world-first research into an enzyme believed to play an essential role in the spread of breast cancer to the bone. Finishing his PhD last year, we’re excited to share with you the results of his research as he moves one step closer to a new treatment for secondary breast cancer. read more
Ground-breaking research is underway boosting the body’s own immune system to fight the most common cancers affecting Australian families, including breast cancer. The treatment is known as immunotherapy, and whilst it’s currently revolutionising blood cancer treatment, when it comes to solid cancers like breast cancer it’s not known to be as effective. read more